CTOs on the Move

Contego Medical

www.contegomedical.com

 
Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Contego Medical raised $22M on 01/13/2020

Similar Companies

Photo-Stat

Photo-Stat, LP is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WS Audiology

Formed in 2019, through the merger of Sivantos and Widex, WS Audiology combines more than 140 years experience in pioneering the use of technology to help people with hearing loss hear the sounds that make life wonderful. Today, one out of three hearing aids is made by us and we are active in over 125 markets, employing close to 12,000 people worldwide. Our broad portfolio of leading hearing-related products and services generates annual revenues of more than € 2 billion. WS Audiology is privately owned by the Tøpholm and Westermann families, as well as funds under the management of EQT. As a global leader, our ambition is to unlock human potential by making wonderful sound part of everyone`s life.

Fourroux Orthotics and Prosthetics

Fourroux Orthotics and Prosthetics is a Huntsville, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mexpo International

Mexpo International is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Spirox

Spirox is a Menlo Park, CA-based medical device company. The company intends to use the funds to complete development, seek US marketing authorization, and initiate product commercialization.